Novo Nordisk Enters Oversold Territory - Tale of the Tape

By
A A A

Novo Nordisk 's ( NVO ) share price has entered into oversold territory with an RSI value of 23.85. The Zacks Consensus Estimate on Novo Nordisk's earnings for the full year period have moved higher by 16 cents over the past two months to $8.27 per share. Currently, Novo Nordisk is a Zacks #2 Rank ("Buy"), suggesting that now might be a good time to get in on ( NVO ) after its recent drop.



NOVO-NORDISK AS (NVO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: NVO

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

50%

Most Active by Volume

91,252,153
  • $13.78 ▼ 4.31%
68,133,496
  • $12.93 ▲ 6.77%
57,268,074
  • $46.13 ▲ 2.47%
43,432,023
  • $105.22 ▲ 0.37%
40,880,685
  • $13.46 ▲ 8.90%
40,712,405
  • $98.62 ▲ 0.82%
39,776,976
  • $16.72 ▲ 0.72%
34,688,871
  • $11.16 ▲ 3.05%
As of 10/24/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com